Mota T Cell Therapy

Mota T Cell Therapy

ziviso

Masero eT chikamu chemuviri wekudzivirira chirwere chinoshandiswa nemuviri kurwisa kenza nezvimwe zvirwere. Masero eT akachinjwa majini anozivikanwa semasero echimeric antigen receptor T (CAR T). Ichishandisa kugona kwemasero eT akachinjwa kuwana nekubvisa masero ekenza, kurapwa nemasero eCAR T kunovandudza zvipingamupinyi zvemuviri kubva kuchirwere ichi.

nzira

Sekupa ropa, ropa rinounganidzwa kubva kuvarwere kuti riparadzanise masero eT. Aya maT masero anobva agadziridzwa murabhoritari pasi pekutariswa kwenyanzvi kuratidza Chimeric Antigen Receptor. Pamberi peCar T cell management, varwere vanofanirwa kuitiswa chemotherapy kugadzirira miviri yavo yeCar T cell therapy. Kana aiswa, masero eCar T anotarisirwa kuziva uye kudzikamisa masero egomarara nekuita kuti immune system yemuviri ishande.

Zviratidzo

Kubva 2017, iyo FDA yakabvumidza matanhatu eCar T cell marapirwo ekurapa gomarara reropa seLymphomas, mamwe marudzi eLeukemia uye nguva pfupi yadarika, akawanda myeloma. Varwere vanokodzera Car T cell therapy vanofanirwa kusangana neFDA maitiro uye kuve neutano hwakanaka hwese kubata nguva yekumirira uye zvinogona kuitika.

Advantages

• Nguva pfupi yekurapa
• Varwere vanogona kupora zvakanaka nekutarisirwa kwakakodzera uye nekutarisa kwemavhiki 2-3
• Kurumidza kupindira nguva uye kamwe chete infusion yeCar T masero